BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23077237)

  • 21. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population.
    Marples B; Joiner MC
    Radiat Res; 1993 Jan; 133(1):41-51. PubMed ID: 8434112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
    Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro studies of PDR brachytherapy].
    Fritz P; Frank C; Weber KJ
    Strahlenther Onkol; 1998 Jul; 174(7):365-74. PubMed ID: 9689958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.
    Brenner DJ
    Semin Radiat Oncol; 2008 Oct; 18(4):234-9. PubMed ID: 18725109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repairable-conditionally repairable damage model based on dual Poisson processes.
    Lind BK; Persson LM; Edgren MR; Hedlöf I; Brahme A
    Radiat Res; 2003 Sep; 160(3):366-75. PubMed ID: 12926995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
    Unkel S; Belka C; Lauber K
    Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of changing the radiation dose range on the in vitro cytogenetic dose response to gamma-rays.
    Vinnikov VA
    Int J Radiat Biol; 2024; 100(6):875-889. PubMed ID: 38647504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical Note: Break-even dose level for hypofractionated treatment schedules.
    Böhlen TT; Germond JF; Bourhis J; Vozenin MC; Bailat C; Bochud F; Moeckli R
    Med Phys; 2021 Nov; 48(11):7534-7540. PubMed ID: 34609744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superfractionation as a potential hypoxic cell radiosensitizer: prediction of an optimum dose per fraction.
    Daşu A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1083-94. PubMed ID: 10192360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy.
    Wheldon TE; Deehan C; Wheldon EG; Barrett A
    Radiother Oncol; 1998 Mar; 46(3):285-95. PubMed ID: 9572622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model.
    Wennberg B; Lax I
    Acta Oncol; 2013 Jun; 52(5):902-9. PubMed ID: 23327339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
    Brown JM; Carlson DJ; Brenner DJ
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):254-62. PubMed ID: 24411596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equivalence of the linear-quadratic and two-lesion kinetic models.
    Guerrero M; Stewart RD; Wang JZ; Li XA
    Phys Med Biol; 2002 Sep; 47(17):3197-209. PubMed ID: 12361218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accounting for overdispersion of lethal lesions in the linear quadratic model improves performance at both high and low radiation doses.
    Shuryak I; Cornforth MN
    Int J Radiat Biol; 2021; 97(1):50-59. PubMed ID: 32552223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substructure in the radiation survival response at low dose in cells of human tumor cell lines.
    Skarsgard LD; Skwarchuk MW; Wouters BG; Durand RE
    Radiat Res; 1996 Oct; 146(4):388-98. PubMed ID: 8927711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linear-quadratic model underestimates sparing effect of small doses per fraction in rat spinal cord.
    Wong CS; Minkin S; Hill RP
    Radiother Oncol; 1992 Mar; 23(3):176-84. PubMed ID: 1574596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Might intrinsic radioresistance of human tumour cells be induced by radiation?
    Lambin P; Malaise EP; Joiner MC
    Int J Radiat Biol; 1996 Mar; 69(3):279-90. PubMed ID: 8613677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of fractionated doses of radiation on mouse spinal cord.
    Lo Y; Taylor JM; McBride WH; Withers HR
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):309-17. PubMed ID: 8407405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy.
    Wang JZ; Huang Z; Lo SS; Yuh WT; Mayr NA
    Sci Transl Med; 2010 Jul; 2(39):39ra48. PubMed ID: 20610850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.